The Late-Breaking Clinical Trial submission portal is currently closed. To be added to our mailing list and receive future updates, subscribe here.
Physicians and researchers present groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs. Each presentation is followed by a discussion and Q&A with a panel of expert faculty.
The 2022 late-breaking clinical trials were presented on Monday, October 31 (The VEINS) and Tuesday-Wednesday, November 1-2 (VIVA).
See the complete agendas for VIVA and The VEINS 2022.
VIVA embargoes Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.
To be added to our mailing list and receive future updates, subscribe here.